Mazhar Ajaz

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

Célèste Lebbé, Nicolás Meyer, Laurent Mortier et al. · Journal of Clinical Oncology · 2019 · 384 citations · Full text

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 259 citations · Full text

Phase II multicenter proof of concept study of AZD4547 in<i> FGFR</i> amplified tumours.

Elizabeth Smyth, Nicholas C. Turner, Clare Peckitt et al. · Journal of Clinical Oncology · 2015 · 44 citations

Pathology, Concept Study, Cancer Biology +17

The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid Cancers

Mohammed Ismael, R.P. Webb, Mazhar Ajaz et al. · Cancers · 2019 · 28 citations · Full text

Two dosing regimens of nivolumab (NIVO) plus ipilimumab (IPI) for advanced (adv) melanoma: Three-year results of CheckMate 511.

Célèste Lebbé, Nicolás Meyer, Laurent Mortier et al. · Journal of Clinical Oncology · 2021 · 27 citations

Checkmate 511, Oncology, Ipi 3 +14